caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1689767261

Siddhartha GangulyM.D.

HematologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Siddhartha Ganguly's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 45 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Anurag Singh
Hematology-Oncology · Westwood, KS
1161,617
Omar Aljitawi
Hematopoietic Cell Transplantation and Cellular Therapy · Rochester, NY
961,508
Tara Lin
Hematology-Oncology · Kansas City, KS
91881
Lowell Tilzer
Pathology · Kansas City, KS
83524
Mark Cunningham
Pathology · Kansas City, KS
69713
PERSONS, DIANE69356
Janet Woodroof
Pathology · Kansas City, KS
62420
Pauline Sleder
Diagnostic Radiology · Kansas City, KS
56220
Da Zhang
Pathology · Kansas City, KS
50300
COX, GLENDON49192
Wei Cui
Hematology-Oncology · Kansas City, KS
47213
Mary Luder
Nurse Practitioner · Overland Park, KS
46478
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
157
Unique beneficiaries
—
Total services
365
Distinct HCPCS
6
Medicare payment
$30K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 47 Hematology providers in TX — below median (cohort median 530).
PRESCRIBING · PART D · 2024
Total Rx claims
274
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
6
Brand share
58.4%
Top prescribed drugs
Valacyclovir Hcl72 claims
Lenalidomide71 claims
Lenalidomide42 claims
Ruxolitinib Phosphate30 claims
Dexamethasone30 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
3
By payment type
Consulting Fee$2K
Food and Beverage$104